Logo image of IBRX

IMMUNITYBIO INC (IBRX) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:IBRX - US45256X1037 - Common Stock

3.95 USD
+0.93 (+30.79%)
Last: 1/15/2026, 8:00:02 PM
4.945 USD
+1 (+25.19%)
Pre-Market: 1/16/2026, 4:01:09 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
IBRX revenue by date.IBRX revenue by date.
240K
-74.19%
622K
159.17%
14.745M
2,270.58%
113.12M
667.18%
218.35M
93.03%
532.39M
143.82%
995.05M
86.90%
1.892B
90.14%
3.304B
74.63%
5.56B
68.28%
7.366B
32.48%
9.694B
31.60%
EBITDA
YoY % growth
IBRX ebitda by date.IBRX ebitda by date.
-332.36M
-5.16%
-342.852M
-3.16%
-326.628M
4.73%
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
IBRX ebit by date.IBRX ebit by date.
-350.62M
-6.16%
-361.364M
-3.06%
-344.182M
4.75%
-270.424M
21.43%
-224.069M
17.14%
31.875M
114.23%
441.99M
1,286.64%
1.249B
182.59%
2.494B
99.68%
4.488B
79.95%
6.072B
35.29%
8.119B
33.71%
Operating Margin
IBRX operating margin by date.IBRX operating margin by date.
-146,091.67%-58,097.11%-2,334.23%-239.06%-102.62%5.99%44.42%66.01%75.48%80.72%82.43%83.75%
EPS
YoY % growth
IBRX eps by date.IBRX eps by date.
-1.05
-17.98%
-1.13
-7.62%
-0.61
46.02%
-0.46
24.42%
-0.33
28.76%
-0.08
75.16%
0.38
562.50%
1.04
175.68%
2.15
106.86%
3.88
80.33%
5.01
29.04%
6.55
30.75%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.11
-24.67%
-0.08
45.60%
-0.09
13.30%
-0.08
-16.57%
-0.09
22.73%
Revenue
Q2Q % growth
36.7M
385.96%
40.035M
142.39%
45.747M
73.12%
52.081M
62.44%
59.012M
60.80%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-75.125M
-8.25%
-59.555M
7.56%
-59.944M
15.91%
-59.854M
-7.59%
-60.43M
19.56%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.07
41.67%
-0.110.0436.46%
Q2 2025
Q2Q % growth
-0.10
50.00%
-0.110.0110.87%
Q1 2025
Q2Q % growth
-0.15
25.00%
-0.13-0.02-14.89%
Q4 2024
Q2Q % growth
-0.09
74.29%
-0.200.1155.88%
Q3 2024
Q2Q % growth
-0.12
36.84%
-0.180.0634.64%
Q2 2024
Q2Q % growth
-0.20
37.50%
-0.17-0.03-15.34%
Q1 2024
Q2Q % growth
-0.20
25.93%
-0.16-0.04-22.55%
Q4 2023
Q2Q % growth
-0.35
-29.63%
-0.18-0.17-90.63%
Q3 2023
Q2Q % growth
-0.19
32.14%
-0.260.0726.95%
Q2 2023
Q2Q % growth
-0.32
-33.33%
-0.24-0.08-33.50%
Q1 2023
Q2Q % growth
-0.27
-3.85%
-0.280.011.96%
Q4 2022
Q2Q % growth
-0.27
-17.39%
-0.22-0.05-20.32%
Q3 2022
Q2Q % growth
-0.28
-27.27%
-0.23-0.05-19.35%
Q2 2022
Q2Q % growth
-0.24
-4.35%
-0.240.001.96%
Q1 2022
Q2Q % growth
-0.26
-23.81%
-0.22-0.04-15.86%
Q4 2021
Q2Q % growth
-0.23
23.33%
-0.21-0.02-7.38%
Q3 2021
Q2Q % growth
-0.22
-10.00%
-0.20-0.02-7.84%
Q2 2021
Q2Q % growth
-0.23
-15.00%
-0.12-0.11-87.91%
Q1 2021
Q2Q % growth
-0.21
-10.53%
-0.420.2149.78%
Q4 2020
Q2Q % growth
-0.30 -0.18-0.12-63.40%
Q3 2020
Q2Q % growth
-0.20 -0.18-0.02-8.93%
Q2 2020
Q2Q % growth
-0.20 -0.19-0.01-3.20%
Q1 2020
Q2Q % growth
-0.19 -0.17-0.02-9.57%
IBRX Yearly EPS VS EstimatesIBRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 4 6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
32.061M
425.07%
32.518M-457K-1.41%
Q2 2025
Q2Q % growth
26.425M
2,423.88%
23.223M3.202M13.79%
Q1 2025
Q2Q % growth
16.517M
41,192.50%
16.335M182K1.11%
Q4 2024
Q2Q % growth
7.552M
5,333.09%
7.973M-421K-5.28%
Q3 2024
Q2Q % growth
6.106M
7,346.34%
2.985M3.121M104.56%
Q2 2024
Q2Q % growth
1.047M
2,453.66%
2.57M-1.523M-59.26%
Q1 2024
Q2Q % growth
40K
-88.89%
25.5K14.5K56.86%
Q4 2023
Q2Q % growth
139K
98.57%
25.5K113.5K445.10%
Q3 2023
Q2Q % growth
82K
-31.67%
25.5K56.5K221.57%
Q2 2023
Q2Q % growth
41K
2.50%
25.5K15.5K60.78%
Q1 2023
Q2Q % growth
360K
3,500.00%
25.5K334.5K1,311.76%
Q4 2022
Q2Q % growth
70K
-82.05%
25.5K44.5K174.51%
Q3 2022
Q2Q % growth
120K
71.43%
25.5K94.5K370.59%
Q2 2022
Q2Q % growth
40K
-88.24%
25.5K14.5K56.86%
Q1 2022
Q2Q % growth
10K
-92.86%
25.5K-15.5K-60.78%
Q4 2021
Q2Q % growth
390K
360.00%
25.5K364.5K1,429.41%
Q3 2021
Q2Q % growth
70K
-53.33%
25.5K44.5K174.51%
Q2 2021
Q2Q % growth
340K
-22.73%
25.5K314.5K1,233.33%
Q1 2021
Q2Q % growth
140K
-17.65%
25.5K114.5K449.02%
Q4 2020
Q2Q % growth
-150K 15.3K-165.3K-1,080.39%
Q3 2020
Q2Q % growth
150K 7.65K142.35K1,860.78%
Q2 2020
Q2Q % growth
440K 7.65K432.35K5,651.63%
IBRX Yearly Revenue VS EstimatesIBRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-7.84% 3.51% 0% 12.23%
Revenue-0.05% 1.98% 0% 5.1%